Perspectives on Clinical Applications of CTCs

Rajan P. Kulkarni, Stefanie S. Jeffrey

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations

Abstract

Though technologies for isolating and analyzing CTCs have advanced rapidly, there has been little clinical uptake of these technologies, despite the potential to assist medical decision-making. The first clinical studies examined the enumeration of CTCs and there were differing outcomes of utility; many of these studies were hampered by small sample sizes. More recent clinical studies have focused on molecular and genetic analysis of CTCs, rather than mere enumeration, to be utilized as a companion diagnostic to determine if a druggable mutation is present or absent (such as the T790M EGFR or V600E BRAF mutations). The rise of genetically targeted therapies has increased interest in CTC analysis in a clinical setting, particularly to obtain actionable information. CTCs hold the potential to assist with clinical decision-making, though further controlled trials will be necessary to better realize this promise.

Original languageEnglish (US)
Title of host publicationCurrent Cancer Research
PublisherSpringer Nature
Pages315-323
Number of pages9
DOIs
StatePublished - 2016
Externally publishedYes

Publication series

NameCurrent Cancer Research
ISSN (Print)2199-2584
ISSN (Electronic)2199-2592

Keywords

  • AR-V7
  • BRAF
  • Breast cancer
  • Circulating tumor cell (CTC)
  • Companion diagnostics
  • EGFR
  • Lung cancer
  • Melanoma
  • Prostate cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint

Dive into the research topics of 'Perspectives on Clinical Applications of CTCs'. Together they form a unique fingerprint.

Cite this